{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T05:45:11Z","timestamp":1780465511935,"version":"3.54.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institute of Health","award":["DC010489"],"award-info":[{"award-number":["DC010489"]}]},{"name":"National Institute of Health","award":["DC011793"],"award-info":[{"award-number":["DC011793"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.heares.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T21:07:24Z","timestamp":1436303244000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Canertinib induces ototoxicity in three preclinical models"],"prefix":"10.1016","volume":"328","author":[{"given":"Jian","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Kopecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalian","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C.","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"DeCook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2015.07.002_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/(SICI)1098-1136(20000115)29:2<104::AID-GLIA2>3.0.CO;2-2","article-title":"Role of neuregulins in glial cell development","volume":"29","author":"Adlkofer","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.heares.2015.07.002_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ctrv.2013.05.005","article-title":"Emerging toxicities in the treatment of non-small cell lung cancer: ocular disorders","volume":"40","author":"Agustoni","year":"2014","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.heares.2015.07.002_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/lary.21913","article-title":"The clinical implications of antitumor immunity in head and neck cancer","volume":"122","author":"Allen","year":"2012","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heares.2015.07.002_bib4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/j.seminoncol.2003.08.009","article-title":"CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer","volume":"30","author":"Allen","year":"2003","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<188::AID-IJC16>3.0.CO;2-1","article-title":"Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse","volume":"84","author":"Almadori","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.heares.2015.07.002_bib6","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ctrv.2012.01.001","article-title":"New therapies in HER2-positive breast cancer: a major step towards a cure of the disease?","volume":"38","author":"Awada","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.heares.2015.07.002_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.heares.2013.06.004","article-title":"Prophylactic and therapeutic functions of drug combinations against noise-induced hearing loss","volume":"304","author":"Bao","year":"2013","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib8","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1523\/JNEUROSCI.5277-04.2005","article-title":"Requirement of nicotinic acetylcholine receptor subunit beta2 in the maintenance of spiral ganglion neurons during aging","volume":"25","author":"Bao","year":"2005","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib9","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/nn1342","article-title":"Activity-dependent transcription regulation of PSD-95 by neuregulin-1 and Eos","volume":"7","author":"Bao","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1083\/jcb.200212085","article-title":"Back signaling by the Nrg-1 intracellular domain","volume":"161","author":"Bao","year":"2003","journal-title":"J.\u00a0Cell. Biol."},{"key":"10.1016\/j.heares.2015.07.002_bib11","first-page":"4450","article-title":"The biological and biochemical effects of CP-654577, a selective erbB2 kinase inhibitor, on human breast cancer cells","volume":"63","author":"Barbacci","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.heares.2015.07.002_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3816\/CLC.2010.n.101","article-title":"A\u00a0multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer","volume":"11","author":"Butts","year":"2010","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.heares.2015.07.002_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/nn1139","article-title":"Disruption of ErbB receptor signaling in adult non-myelinating Schwann cells causes progressive sensory loss","volume":"6","author":"Chen","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib14","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1007\/s00018-006-6202-8","article-title":"Structural biology of protein tyrosine kinases","volume":"63","author":"Cowan-Jacob","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.heares.2015.07.002_bib15","first-page":"CD009256","article-title":"Cisplatin versus carboplatin in combination with third-generation drugs for advanced non-small cell lung cancer","volume":"8","author":"de Castria","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heares.2015.07.002_bib16","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.heares.2011.08.002","article-title":"Cisplatin ototoxicity in rat cochlear organotypic cultures","volume":"282","author":"Ding","year":"2011","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib17","series-title":"Cochlear Hair Cell Densities and Inner-ear Staining techniques. James F. Willott. Handbook of Mouse Auditory Research","first-page":"189","author":"Ding","year":"2001"},{"key":"10.1016\/j.heares.2015.07.002_bib18","doi-asserted-by":"crossref","first-page":"e79817","DOI":"10.1371\/journal.pone.0079817","article-title":"Addition of exogenous NAD(+) prevents mefloquine-induced neuroaxonal and hair cell degeneration through reduction of caspase-3-mediated apoptosis in cochlear organotypic cultures","volume":"8","author":"Ding","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.heares.2015.07.002_bib19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1749-6632.1999.tb08640.x","article-title":"Selective loss of inner hair cells and type-I ganglion neurons in carboplatin-treated chinchillas. Mechanisms of damage and protection","volume":"884","author":"Ding","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.heares.2015.07.002_bib20","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1158\/1078-0432.CCR-07-2248","article-title":"Mechanisms of acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer","volume":"14","author":"Engelman","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heares.2015.07.002_bib21","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1523\/JNEUROSCI.21-16-06170.2001","article-title":"Spatial shaping of cochlear innervation by temporally regulated neurotrophin expression","volume":"21","author":"Farinas","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib22","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1016\/j.neurobiolaging.2009.09.009","article-title":"F1 (CBAxC57) mice show superior hearing in old age relative to their parental strains: hybrid vigor or a new animal model for \u201cgolden ears\u201d?","volume":"32","author":"Frisina","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.heares.2015.07.002_bib23","doi-asserted-by":"crossref","first-page":"6213","DOI":"10.1523\/JNEUROSCI.17-16-06213.1997","article-title":"Lack of neurotrophin 3 causes losses of both classes of spiral ganglion neurons in the cochlea in a region-specific fashion","volume":"17","author":"Fritzsch","year":"1997","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0079-6123(03)46017-2","article-title":"Neurotrophins in the ear: their roles in sensory neuron survival and fiber guidance","volume":"146","author":"Fritzsch","year":"2004","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.heares.2015.07.002_bib25","first-page":"3","article-title":"Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer","volume":"15","author":"Fry","year":"2000","journal-title":"Anticancer Drug Des."},{"key":"10.1016\/j.heares.2015.07.002_bib26","doi-asserted-by":"crossref","first-page":"17005","DOI":"10.1073\/pnas.1008938107","article-title":"Nonneuronal cells regulate synapse formation in the vestibular sensory epithelium via erbB-dependent BDNF expression","volume":"107","author":"Gomez-Casati","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.heares.2015.07.002_bib27","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/ar.22587","article-title":"The Trk A, B, C's of neurotrophins in the cochlea","volume":"295","author":"Green","year":"2012","journal-title":"Anat. Rec. Hob."},{"key":"10.1016\/j.heares.2015.07.002_bib28","first-page":"12","article-title":"Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system","volume":"7","author":"Han","year":"2008","journal-title":"J.\u00a0Biol."},{"key":"10.1016\/j.heares.2015.07.002_bib29","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5955(01)00360-4","article-title":"Reciprocal signaling between spiral ganglion neurons and Schwann cells involves neuregulin and neurotrophins","volume":"161","author":"Hansen","year":"2001","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib30","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1002\/lary.24948","article-title":"A\u00a0low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity","volume":"125","author":"Harrison","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heares.2015.07.002_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ydbio.2004.07.021","article-title":"Cranial sensory neuron development in the absence of brain-derived neurotrophic factor in BDNF\/Bax double null mice","volume":"275","author":"Hellard","year":"2004","journal-title":"Dev. Biol."},{"key":"10.1016\/j.heares.2015.07.002_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000227455","article-title":"Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer","volume":"52","author":"Hirono","year":"1995","journal-title":"Oncology"},{"key":"10.1016\/j.heares.2015.07.002_bib33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s10162-011-0278-z","article-title":"Hair cell toxicity in anti-cancer drugs: evaluating an anti-cancer drug library for independent and synergistic toxic effects on hair cells using the zebrafish lateral line","volume":"12","author":"Hirose","year":"2011","journal-title":"J.\u00a0Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2015.07.002_bib34","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s10162-002-3008-8","article-title":"ErbB expression: the mouse inner ear and maturation of the mitogenic response to heregulin","volume":"4","author":"Hume","year":"2003","journal-title":"J.\u00a0Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2015.07.002_bib35","first-page":"165","article-title":"The biology of erbB-2\/neu\/HER-2 and its role in cancer","volume":"1198","author":"Hynes","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heares.2015.07.002_bib36","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1200\/JCO.2007.11.1336","article-title":"Multicenter, randomized, phase II trial of CI-1033, an irreversible pan-ERBB inhibitor, for previously treated advanced non small-cell lung cancer","volume":"25","author":"Janne","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.heares.2015.07.002_bib38","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.heares.2015.07.002_bib39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00666183","article-title":"The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: results of a 10 year follow-up study","volume":"29","author":"Klijn","year":"1994","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.heares.2015.07.002_bib40","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/02841860802213328","article-title":"Irreversible ototoxicity associated with the use of erlotinib in a patient with pancreatic cancer","volume":"47","author":"Koutras","year":"2008","journal-title":"Acta Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/378394a0","article-title":"Requirement for neuregulin receptor erbB2 in neural and cardiac development","volume":"378","author":"Lee","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.heares.2015.07.002_bib42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1464-410X.1997.30412.x","article-title":"A\u00a0potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma","volume":"79","author":"Leung","year":"1997","journal-title":"Br. J. Urol."},{"key":"10.1016\/j.heares.2015.07.002_bib43","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1024\/0369-8394.94.6.187","article-title":"Platinum compounds: metabolism, toxicity and supportive strategies","volume":"94","author":"Lipp","year":"2005","journal-title":"Praxis (Bern 1994)"},{"key":"10.1016\/j.heares.2015.07.002_bib44","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.heares.2013.03.012","article-title":"Insensitivity of the audiogram to carboplatin induced inner hair cell loss in chinchillas","volume":"302","author":"Lobarinas","year":"2013","journal-title":"Hear Res."},{"key":"10.1016\/j.heares.2015.07.002_bib45","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12094-012-0964-2","article-title":"An update on molecularly targeted therapies in second- and third-line treatment in non-small cell lung cancer: focus on EGFR inhibitors and anti-angiogenic agents","volume":"15","author":"Majem","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib46","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0301-2115(96)02630-9","article-title":"Overexpression of the oncogene c-erbB-2 (HER2\/neu) in ovarian cancer: a new prognostic factor","volume":"71","author":"Meden","year":"1997","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.heares.2015.07.002_bib47","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/378386a0","article-title":"Multiple essential functions of neuregulin in development","volume":"378","author":"Meyer","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.heares.2015.07.002_bib48","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0169-328X(97)00355-0","article-title":"ARIA is heavily expressed in rat peripheral auditory and vestibular ganglia","volume":"54","author":"Morley","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.heares.2015.07.002_bib49","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0169-328X(97)00272-6","article-title":"Identification of the subunits of the nicotinic cholinergic receptors in the rat cochlea using RT-PCR and in situ hybridization","volume":"53","author":"Morley","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.heares.2015.07.002_bib50","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.brainres.2006.02.090","article-title":"A\u00a0disorganized innervation of the inner ear persists in the absence of ErbB2","volume":"1091","author":"Morris","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.heares.2015.07.002_bib51","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/17460441.2011.562887","article-title":"The design and screening of drugs to prevent acquired sensorineural hearing loss","volume":"6","author":"Mukherjea","year":"2011","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.heares.2015.07.002_bib52","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s101620010043","article-title":"Targeted mutation of the gene for cellular glutathione peroxidase (Gpx1) increases noise-induced hearing loss in mice","volume":"1","author":"Ohlemiller","year":"2000","journal-title":"J.\u00a0Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.heares.2015.07.002_bib53","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0378-5955(00)00191-X","article-title":"Vulnerability to noise-induced hearing loss in \u2018middle-aged\u2019 and young adult mice: a dose-response approach in CBA, C57BL, and BALB inbred strains","volume":"149","author":"Ohlemiller","year":"2000","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib54","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1200\/JCO.2006.08.9599","article-title":"Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors","volume":"25","author":"Oldenburg","year":"2007","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.heares.2012.01.009","article-title":"Screening for chemicals that affect hair cell death and survival in the zebrafish lateral line","volume":"288","author":"Ou","year":"2012","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib56","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.critrevonc.2011.11.010","article-title":"Second-generation irreversible epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs): a better mousetrap? A review of the clinical evidence","volume":"83","author":"Ou","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.heares.2015.07.002_bib57","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","article-title":"Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain","volume":"2","author":"Pao","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.heares.2015.07.002_bib58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/187152009787047752","article-title":"Tyrosine kinase blockers: new hope for successful cancer therapy","volume":"9","author":"Pytel","year":"2009","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.heares.2015.07.002_bib59","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K","article-title":"Organization of the lateral line system in embryonic zebrafish","volume":"421","author":"Raible","year":"2000","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.heares.2015.07.002_bib60","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/jcp.38.11.1225","article-title":"Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer","volume":"38","author":"Sainsbury","year":"1985","journal-title":"J.\u00a0Clin. Pathol."},{"key":"10.1016\/j.heares.2015.07.002_bib61","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ar.22578","article-title":"Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention","volume":"295","author":"Schacht","year":"2012","journal-title":"Anat. Rec. Hob."},{"key":"10.1016\/j.heares.2015.07.002_bib62","first-page":"367","article-title":"Gains of the relative genomic content of erbB-1 and erbB-2 in prostate carcinoma and their association with metastasis","volume":"14","author":"Schwartz","year":"1999","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib63","doi-asserted-by":"crossref","first-page":"75ra26","DOI":"10.1126\/scitranslmed.3002003","article-title":"\u201cGenotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors\u201d","volume":"3","author":"Sequist","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.heares.2015.07.002_bib64","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa050753","article-title":"Erlotinib in previously treated non-small-cell lung cancer","volume":"353","author":"Shepherd","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.heares.2015.07.002_bib65","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0093-7754(01)90285-4","article-title":"CI-1033, a pan-erbB tyrosine kinase inhibitor","volume":"28","author":"Slichenmyer","year":"2001","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib66","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1523\/JNEUROSCI.0733-04.2004","article-title":"Survival of adult spiral ganglion neurons requires erbB receptor signaling in the inner ear","volume":"24","author":"Stankovic","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib67","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1523\/JNEUROSCI.3940-12.2013","article-title":"Functional mechanotransduction is required for cisplatin-induced hair cell death in the zebrafish lateral line","volume":"33","author":"Thomas","year":"2013","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib68","first-page":"5749","article-title":"ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy","volume":"62","author":"Wakeling","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.heares.2015.07.002_bib69","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1460-9568.2010.07347.x","article-title":"Signaling through erbB receptors is a critical functional regulator in the mature cochlea","volume":"32","author":"Watanabe","year":"2010","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.heares.2015.07.002_bib70","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1200\/JCO.2012.46.1764","article-title":"Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin\/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations","volume":"31","author":"Yang","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.heares.2015.07.002_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.heares.2011.03.002","article-title":"The molecular basis of making spiral ganglion neurons and connecting them to hair cells of the organ of corti","volume":"278","author":"Yang","year":"2011","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib72","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14740338.5.3.383","article-title":"Understanding drug ototoxicity: molecular insights for prevention and clinical management","volume":"5","author":"Yorgason","year":"2006","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.heares.2015.07.002_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0378-5955(02)00339-8","article-title":"Expression of heregulin and ErbB\/Her receptors in adult chinchilla cochlear and vestibular sensory epithelium","volume":"169","author":"Zhang","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2015.07.002_bib74","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/1078-0432.CCR-06-1958","article-title":"Phase I clinical and pharmacodynamic evaluation of oral CI-1033 in patients with refractory cancer","volume":"13","author":"Zinner","year":"2007","journal-title":"Clin. Cancer Res."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595515001422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595515001422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T22:24:36Z","timestamp":1566944676000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595515001422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":74,"alternative-id":["S0378595515001422"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2015.07.002","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Canertinib induces ototoxicity in three preclinical models","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}